Knowledge@Australian School of Business

previous articles articles 16 to 19 of 19

thumbnail Pharma Is at Pains to Replace Blockbusters: Has It Found the Cure?
As the pharmaceutical industry comes to grips with the expiration of some $130 billion in patented products over the next four years, executives can no longer bank on a single drug like Lipitor to drive earnings. Instead, they are aiming to diversify their drug portfolios, hoping to develop products for far less than the $800 million-plus figure often cited as the price of bringing a new drug to market. According to industry experts, new paths involve innovative business models and unfamiliar risks, including allowing outsiders to see company secrets at earlier stages and mimicking biotech venture capital models.
From: February 03, 2010 thumbnail Rx for the Pharmaceutical Industry: Focus on Innovation, Not Marketing
The good news for the pharmaceutical industry is that, short-term, it may emerge as a winner in the health care reform battle as new customers enter the system and price protections remain in force. The bad news is that while big pharma has used increasingly large megamergers to support its reliance on blockbuster products, it still faces the long-term need to develop fundamentally new business models to cope with its most significant problem -- a failure to come up with new treatments, according to Wharton faculty.
From: October 14, 2009 thumbnail Bangkok's Bumrungrad Hospital: Expanding the Footprint of Offshore Health Care
Thailand's Bumrungrad International Hospital is one of a growing number of institutions making a name for themselves among "medical tourists" by offering patients from Boston to Bahrain a combination of lower-cost, state-of-the-art medical care along with service worthy of a five-star hotel. But what will it take for such hospitals to gain acceptance among national policy makers, major insurers and employers? Mack Banner, CEO of Bumrungrad, and Kenneth Mays, the hospital's director of marketing, recently met with Ravi Aron, a senior fellow at Wharton, to discuss the future of offshore health care.
From: September 02, 2009 thumbnail One Way to Lower Health Costs: Pay People to Be Healthy
When employers want their employees to live healthier lifestyles -- to lose weight, stop smoking and exercise regularly -- nothing works like cash, according to research led by Wharton faculty. While some may wince at the notion of paying people to do the right thing, the research found that the incentives cost less than the diseases they prevent.
From: June 24, 2009




Sign Up / Sign In

Email Address:   
Password: 

Not Yet a Member?

  • Analysis of the latest business news delivered fortnightly to your inbox
  • Join a global network of leading business professionals
 

Knowledge@Australian School of Business